Author:
Souto-Guevara Cecilia A.,Obiol Diego,Bruno Camila L.,Ferreira-Gomes Mariela S.,Rossi Juan Pablo F. C.,Costabel Marcelo D.,Mangialavori Irene C.
Abstract
AbstractOur research aimed to elucidate the mechanism by which aurintricarboxylic acid (ATA) inhibits plasma membrane Ca2+-ATPase (PMCA), a crucial enzyme responsible for calcium transport. Given the pivotal role of PMCA in cellular calcium homeostasis, understanding how it is inhibited by ATA holds significant implications for potentially regulating physiopathological cellular processes in which this pump is involved. Our experimental findings revealed that ATA employs multiple modes of action to inhibit PMCA activity, which are influenced by ATP but also by the presence of calcium and magnesium ions. Specifically, magnesium appears to enhance this inhibitory effect. Our experimental and in-silico results suggest that, unlike those reported in other proteins, ATA complexed with magnesium (ATA·Mg) is the molecule that inhibits PMCA. In summary, our study presents a novel perspective and establishes a solid foundation for future research efforts aimed at the development of new pharmacological molecules both for PMCA and other proteins.
Funder
Agencia Nacional de Promoción Científica y Tecnológica
Universidad de Buenos Aires
Universidad Nacional del Sur
Publisher
Springer Science and Business Media LLC
Reference45 articles.
1. Kuban-Jankowska, A. et al. Redox process is crucial for inhibitory properties of aurintricarboxylic acid against activity of YopH: Virulence factor of Yersinia pestis. Oncotarget 6(21), 18364–18373. https://doi.org/10.18632/oncotarget.4625 (2015).
2. Kuban-Jankowska, A., Sahu, K. K., Gorska-Ponkowska, M., Tuszynski, J. A. & Wozniak, M. Inhibitory activity of iron chelators ATA and DFO on MCF-7 breast cancer cells and phosphatases PTP1B and SHP2. Anticancer Res. 37(9), 4799–4806 (2017).
3. Roos, A. et al. Identification of aurintricarboxylic acid as a selective inhibitor of the TWEAK-Fn14 signaling pathway in glioblastoma cells. Oncotarget 8(7), 12234–12246. https://doi.org/10.18632/oncotarget.14685 (2017).
4. Liu, T. T. et al. The inhibitory mechanism of aurintricarboxylic acid targeting serine/threonine phosphatase Stp1 in Staphylococcus aureus: Insights from molecular dynamics in-s. Acta Pharmacol. Sin. 40(6), 850–858 (2019).
5. Ghosh, U., Giri, K. & Bhattacharyya, N. P. Interaction of aurintricarboxylic acid (ATA) with four nucleic acid binding proteins DNase I, RNase A, reverse transcriptase and Taq polymerase. Spectrochim. Acta A Mol. Biomol. Spectrosc. 74(5), 1145–1151. https://doi.org/10.1016/j.saa.2009.09.024 (2009).